Astromech acquires Form Bio in $230 million all-stock deal
Astromech, a Dallas AI company developing predictive models of biological change, has acquired Form Bio in an all-stock deal valued at $230 million. Astromech takes over Form Bio's intellectual property, selected contracts and assets, and its team.
The deal combines Astromech's models, which use data across species and evolutionary history to predict biological function, with Form Bio's AI tools for designing genetic medicines, optimising gene therapy vectors and their manufacturing, and checking genomic quality. The companies say the combination should help researchers catch quality problems at the design stage and could reduce the need for purification later in development.
Form Bio's tools support genetic medicine programs at Eli Lilly, Stanford, Coave Therapeutics, Taysha Gene Therapies and Solid Biosciences, according to the company. In work with Cure Rare Disease on Duchenne muscular dystrophy, Form Bio says it raised full-genome content from 13% to 59% in less than 30 days by redesigning the promoter sequence.
Form Bio co-founder and former CEO Andrew Busey becomes Astromech's chief AI officer and head of technology. Both companies came out of Colossal Biosciences. Form Bio launched in 2022 and has raised more than $40 million, while Astromech, co-founded by George Church and Ben Lamm, has raised more than $60 million, according to the announcement.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 17 The Rx Assistant launches Builder, a no-code platform for pharma AI experiences Nov 17 Isomorphic Labs raises $5 billion Series C for AI drug design Nov 17 OpenAI says its computer-use agents can handle clinicians' EHR tasks, with CVS Health and Cigna among users Nov 16 FDA starts calling AI 'Super Intelligence' under Trump executive order Nov 16 Healthcare AI spending grew 2.5x to $3.7B in 2026, Menlo Ventures saysMore from Funding
Nov 17 Siemens to acquire Breker Verification Systems to expand chip verification for AI designs Nov 17 LanceDB raises $57.5 million for its multimodal AI training data platform Nov 17 Ramon.Space raises $124 million for computers that run AI in orbit Nov 17 Pedestal AI emerges from stealth with $4.7 million for supply chain AI agents Nov 17 Aarden raises $8 million for AI land analysis for data centres and energy projectsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Formic Raises $50 Million to Expand Factory Robotics Platform
OpenAI acquires Orchestra Bio to bring AI agents into drug development
Atlas Bio raises $12.5 million for virtual drug trials
Asteromorph Opens Wet Lab for AI Biology Research
Aformic raises $6.95 million for autonomous factory logistics
Daily AI Brief: the AI news that matters, in your inbox.